Login to Your Account



A Growing Market

Combo Drugs Prepare to Tap Underserved Obesity Market

By Trista Morrison


Monday, February 18, 2008
Building a better obesity drug is no easy task. Obesity involves a host of genetic, behavioral, emotional and socio-cultural factors. And any successful drug will be taken by millions of patients, resulting in a safety hurdle that will "probably be greater than for any other drug out there," Kasimov said. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription